Liprolog

国家: 欧盟

语言: 英文

来源: EMA (European Medicines Agency)

现在购买

资料单张 资料单张 (PIL)
30-01-2023
产品特点 产品特点 (SPC)
30-01-2023
公众评估报告 公众评估报告 (PAR)
18-03-2020

有效成分:

insulin lispro

可用日期:

Eli Lilly Nederland B.V.

ATC代码:

A10AB04, A10AD04

INN(国际名称):

insulin lispro

治疗组:

Drugs used in diabetes

治疗领域:

Diabetes Mellitus

疗效迹象:

For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. Liprolog is also indicated for the initial stabilisation of diabetes mellitus.

產品總結:

Revision: 30

授权状态:

Authorised

授权日期:

2001-08-01

资料单张

                                104
B. PACKAGE LEAFLET
105
PACKAGE LEAFLET: INFORMATION FOR THE USER
LIPROLOG 100 UNITS/ML SOLUTION FOR INJECTION IN VIAL
insulin lispro
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
:
1.
What Liprolog is and what it is used for
2.
What you need to know before you use Liprolog
3.
How to use Liprolog
4.
Possible side effects
5.
How to store Liprolog
6.
Contents of the pack and other information
1.
WHAT LIPROLOG IS AND WHAT IT IS USED FOR
Liprolog is used to treat diabetes. Liprolog works more quickly than
normal human insulin because
the insulin molecule has been changed slightly.
You get diabetes if your pancreas does not make enough insulin to
control the level of glucose in your
blood. Liprolog is a substitute for your own insulin and is used to
control glucose in the long term. It
works very quickly and lasts a shorter time than soluble insulin (2 to
5 hours). You should normally
use Liprolog within 15 minutes of a meal.
Your doctor may tell you to use Liprolog as well as a longer-acting
insulin. Each kind of insulin
comes with another patient information leaflet to tell you about it.
Do not change your insulin unless
your doctor tells you to. Be very careful if you do change insulin.
Liprolog is suitable for use in adults and children.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE LIPROLOG
DO NOT USE LIPROLOG
-
if you think
HYPOGLYCAEMIA
(low blood sugar) is starting. Further in this leaflet it tells you
how to
deal with mild hypoglycaemia (see Section 3: If you take more Liprolog
than you need).
-
if you 
                                
                                阅读完整的文件
                                
                            

产品特点

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Liprolog 100 units/ml, solution for injection in vial
Liprolog 100 units/ml, solution for injection in cartridge
Liprolog 100 units/ml KwikPen, solution for injection in a pre-filled
pen
Liprolog 100 units/ml Junior KwikPen, solution for injection in a
pre-filled pen
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains 100 units insulin lispro* (equivalent to 3.5mg).
Vial
Each vial contains 1000 units of insulin lispro in 10 ml solution.
Cartridge
Each cartridge contains 300 units of insulin lispro in 3 ml solution.
KwikPen
Each pre-filled pen contains 300 units of insulin lispro in 3 ml
solution.
Each KwikPen delivers 1-60 units in steps of 1 unit.
Junior KwikPen
Each pre-filled pen contains 300 units of insulin lispro in 3 ml
solution.
Each Junior KwikPen delivers 0.5 – 30 units in steps of 0.5 units.
*produced in
_E.coli_
by recombinant DNA technology.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear, colourless, aqueous solution.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the treatment of adults and children with diabetes mellitus who
require insulin for the maintenance
of normal glucose homeostasis. Liprolog is also indicated for the
initial stabilisation of diabetes
mellitus.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The dosage should be determined by the physician, according to the
requirement of the patient.
_Junior KwikPen _
Liprolog 100 units/ml Junior KwikPen is suitable for patients who may
benefit from finer insulin dose
adjustments.
Liprolog may be given shortly before meals. When necessary Liprolog
can be given soon after meals.
3
Liprolog takes effect rapidly and has a shorter duration of activity
(2 to 5 hours) given subcutaneously
as compared with soluble insulin. This rapid onset of activity allows
a Liprolog injection (or, in the
case of administration by continuous subcutaneous infusion, a Liprolog
bolus) to be given very close
to 
                                
                                阅读完整的文件
                                
                            

其他语言的文件

资料单张 资料单张 保加利亚文 30-01-2023
产品特点 产品特点 保加利亚文 30-01-2023
公众评估报告 公众评估报告 保加利亚文 18-03-2020
资料单张 资料单张 西班牙文 30-01-2023
产品特点 产品特点 西班牙文 30-01-2023
公众评估报告 公众评估报告 西班牙文 18-03-2020
资料单张 资料单张 捷克文 30-01-2023
产品特点 产品特点 捷克文 30-01-2023
公众评估报告 公众评估报告 捷克文 18-03-2020
资料单张 资料单张 丹麦文 30-01-2023
产品特点 产品特点 丹麦文 30-01-2023
公众评估报告 公众评估报告 丹麦文 18-03-2020
资料单张 资料单张 德文 30-01-2023
产品特点 产品特点 德文 30-01-2023
公众评估报告 公众评估报告 德文 18-03-2020
资料单张 资料单张 爱沙尼亚文 30-01-2023
产品特点 产品特点 爱沙尼亚文 30-01-2023
公众评估报告 公众评估报告 爱沙尼亚文 18-03-2020
资料单张 资料单张 希腊文 30-01-2023
产品特点 产品特点 希腊文 30-01-2023
公众评估报告 公众评估报告 希腊文 18-03-2020
资料单张 资料单张 法文 30-01-2023
产品特点 产品特点 法文 30-01-2023
公众评估报告 公众评估报告 法文 18-03-2020
资料单张 资料单张 意大利文 30-01-2023
产品特点 产品特点 意大利文 30-01-2023
公众评估报告 公众评估报告 意大利文 18-03-2020
资料单张 资料单张 拉脱维亚文 30-01-2023
产品特点 产品特点 拉脱维亚文 30-01-2023
公众评估报告 公众评估报告 拉脱维亚文 18-03-2020
资料单张 资料单张 立陶宛文 30-01-2023
产品特点 产品特点 立陶宛文 30-01-2023
公众评估报告 公众评估报告 立陶宛文 18-03-2020
资料单张 资料单张 匈牙利文 30-01-2023
产品特点 产品特点 匈牙利文 30-01-2023
公众评估报告 公众评估报告 匈牙利文 18-03-2020
资料单张 资料单张 马耳他文 30-01-2023
产品特点 产品特点 马耳他文 30-01-2023
公众评估报告 公众评估报告 马耳他文 18-03-2020
资料单张 资料单张 荷兰文 30-01-2023
产品特点 产品特点 荷兰文 30-01-2023
公众评估报告 公众评估报告 荷兰文 18-03-2020
资料单张 资料单张 波兰文 30-01-2023
产品特点 产品特点 波兰文 30-01-2023
公众评估报告 公众评估报告 波兰文 18-03-2020
资料单张 资料单张 葡萄牙文 30-01-2023
产品特点 产品特点 葡萄牙文 30-01-2023
公众评估报告 公众评估报告 葡萄牙文 18-03-2020
资料单张 资料单张 罗马尼亚文 30-01-2023
产品特点 产品特点 罗马尼亚文 30-01-2023
公众评估报告 公众评估报告 罗马尼亚文 18-03-2020
资料单张 资料单张 斯洛伐克文 30-01-2023
产品特点 产品特点 斯洛伐克文 30-01-2023
公众评估报告 公众评估报告 斯洛伐克文 18-03-2020
资料单张 资料单张 斯洛文尼亚文 30-01-2023
产品特点 产品特点 斯洛文尼亚文 30-01-2023
公众评估报告 公众评估报告 斯洛文尼亚文 18-03-2020
资料单张 资料单张 芬兰文 30-01-2023
产品特点 产品特点 芬兰文 30-01-2023
公众评估报告 公众评估报告 芬兰文 18-03-2020
资料单张 资料单张 瑞典文 30-01-2023
产品特点 产品特点 瑞典文 30-01-2023
公众评估报告 公众评估报告 瑞典文 18-03-2020
资料单张 资料单张 挪威文 30-01-2023
产品特点 产品特点 挪威文 30-01-2023
资料单张 资料单张 冰岛文 30-01-2023
产品特点 产品特点 冰岛文 30-01-2023
资料单张 资料单张 克罗地亚文 30-01-2023
产品特点 产品特点 克罗地亚文 30-01-2023
公众评估报告 公众评估报告 克罗地亚文 18-03-2020

搜索与此产品相关的警报

查看文件历史